Senti Biosciences, Inc. (SNTI)

NASDAQ: SNTI · IEX Real-Time Price · USD

0.308

+0.018 (6.03%)

At close: Apr 19, 2024, 4:00 PM

0.317

+0.010 (3.22%)

After-hours: Apr 19, 2024, 7:59 PM EDT

Senti Biosciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020
Revenue	2.56	4.29	2.76	0.57
Revenue Growth (YoY)	-40.25%	55.23%	387.81%	-
Gross Profit	2.56	4.29	2.76	0.57
Selling, General & Admin	37.18	38.23	21.25	9.3
Research & Development	32.15	28.15	21.96	15.96
Other Operating Expenses	25.96	0	0	0
Operating Expenses	95.29	66.37	43.21	25.26
Operating Income	-92.73	-62.08	-40.45	-24.69
Other Expense / Income	-21.67	-3.87	14.87	-4.83
Pretax Income	-71.06	-58.21	-55.32	-19.86
Net Income	-71.06	-58.21	-55.32	-19.86
Shares Outstanding (Basic)	44	26	3	14
Shares Outstanding (Diluted)	44	26	3	14
Shares Change	69.94%	796.58%	-78.99%	-
EPS (Basic)	-1.60	-2.23	-19.00	-1.43
EPS (Diluted)	-1.60	-2.23	-19.00	-1.43
Free Cash Flow	-64.33	-76.27	-40.18	-25.33
Free Cash Flow Per Share	-1.45	-2.92	-13.80	-1.83
Gross Margin	100.00%	100.00%	100.00%	100.00%
Operating Margin	-3620.73%	-1448.53%	-1464.90%	-4362.90%
Profit Margin	-2774.62%	-1358.14%	-2003.59%	-3509.19%
Free Cash Flow Margin	-2511.83%	-1779.51%	-1455.20%	-4475.97%
EBITDA	-65.63	-54.29	-52.31	-17.88
EBITDA Margin	-2562.63%	-1266.68%	-1894.57%	-3158.48%
Depreciation & Amortization	5.43	3.92	3.01	1.99
EBIT	-71.06	-58.21	-55.32	-19.86
EBIT Margin	-2774.62%	-1358.14%	-2003.59%	-3509.19%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).